Alanine aminotransferase 1
AltitudeomicsDB
Protein Official symbol |
GPT |
Aliases |
GPT AAT1 GPT1 |
Chromosomal Location |
16 |
Length |
496 |
Uniprot ID |
P24298 |
EC number |
2.6.1.2 |
Protein family Information(Pfam) |
PF00155; |
PDB id |
None |
InterPro ID |
IPR004839;IPR015424;IPR015422;IPR015421; |
dbSNP |
rs1063739 rs141505249 rs147998249 |
AltitudeomicsDB
Protein 1 |
Protein 2 |
Combine Score |
GLUD2 |
GLUD1 |
0.994 |
GLUD1 |
GOT2 |
0.986 |
GOT1 |
GLUD1 |
0.979 |
GOT1 |
GLUD2 |
0.978 |
GLUD2 |
GOT2 |
0.973 |
GPT |
GOT1 |
0.97 |
GPT |
GOT2 |
0.962 |
F2 |
ALB |
0.96 |
GLUD1 |
OGDH |
0.958 |
GPT |
GLUD1 |
0.952 |
GPT |
GLUD2 |
0.948 |
GOT1 |
OGDH |
0.939 |
GLUD2 |
OGDH |
0.937 |
NAGS |
GLUD1 |
0.935 |
GOT1 |
GOT2 |
0.931 |
GPT |
AGXT |
0.927 |
GLUD2 |
NAGS |
0.925 |
GPT |
ALB |
0.924 |
GPT |
OGDH |
0.921 |
GOT2 |
OGDH |
0.92 |
GPT |
NAGS |
0.919 |
NAGS |
GOT2 |
0.907 |
GOT1 |
NAGS |
0.903 |
GPT |
F2 |
0.902 |
Association with High Altitude
Protein Official symbol |
Source Organism |
Tissue of Expression |
Level of hypoxia |
Altitude |
Duration of experiment |
Level of expression |
Fold change |
Experiment details |
geographical location |
ethnicity of the patients |
Control group |
Control (Fold change) |
Reference (PMID) |
GPT |
Toad |
Heart |
- |
3464 m |
33 day |
upregulated |
2.270195598 |
RNA-seq |
Tibetan Plateau |
Asiatic toad |
1 |
Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - |
28673260 |
Association with TF
TF |
TF Entrez |
Gene |
Gene Entrez |
Type |
PMID |
Database |
ESRRA |
2101 |
GPT |
2875 |
proximal_filtered |
22955619 |
TRANSFAC |
HNF4A |
3172 |
GPT |
2875 |
proximal_filtered |
22955619 |
TRANSFAC |
Association with miRNA
miRTarBase ID |
miRNA |
Species (miRNA) |
Protein Official Symbol |
Human Entrez ID |
Species (Target Gene) |
Experiments |
Support Type |
References (PMID) |
Gene Ontology
ID |
GO ID |
GO Term |
GO Type |
2875 |
GO:0070062 |
extracellular exosome |
GOTERM_CC_DIRECT |
2875 |
GO:0030170 |
pyridoxal phosphate binding |
GOTERM_MF_DIRECT |
2875 |
GO:0008652 |
cellular amino acid biosynthetic process |
GOTERM_BP_DIRECT |
2875 |
GO:0005829 |
cytosol |
GOTERM_CC_DIRECT |
2875 |
GO:0042853 |
L-alanine catabolic process |
GOTERM_BP_DIRECT |
2875 |
GO:0004021 |
ATP-dependent RNA helicase activity |
GOTERM_MF_DIRECT |
2875 |
GO:0005615 |
extracellular space |
GOTERM_CC_DIRECT |
Pathways
Human Entrez ID |
KEGG ID |
KEGG Term |
2875 |
hsa00250 |
Alanine |
2875 |
hsa00220 |
Arginine biosynthesis |
2875 |
hsa01100 |
Metabolic pathways |
2875 |
hsa01200 |
Carbon metabolism |
2875 |
hsa01210 |
2-Oxocarboxylic acid metabolism |
2875 |
hsa01230 |
Biosynthesis of amino acids |
Association with Disease
Protein Official Symbol |
Human Entrez ID |
Disease Name |
Disease Id |
Disease Semantic Type |
Semantic score |
DSI |
DPI |
Disease Type |
GPT |
2875 |
Drug-Induced Liver Disease |
C0860207 |
Disease or Syndrome |
0.32 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Hepatitis, Drug-Induced |
C1262760 |
Disease or Syndrome |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Chemically-Induced Liver Toxicity |
C4279912 |
Disease or Syndrome |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Chemical and Drug Induced Liver Injury |
C4277682 |
Disease or Syndrome |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Reperfusion Injury |
C0035126 |
Injury or Poisoning |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Steatohepatitis |
C2711227 |
Disease or Syndrome |
0.4 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Fatty Liver |
C0015695 |
Disease or Syndrome |
0.4 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Drug-Induced Acute Liver Injury |
C3658290 |
Disease or Syndrome |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Liver Cirrhosis, Experimental |
C0023893 |
Experimental Model of Disease |
0.3 |
0.51 |
0.828 |
disease |
GPT |
2875 |
Liver diseases |
C0023895 |
Disease or Syndrome |
0.4 |
0.51 |
0.828 |
group |
GPT |
2875 |
Liver Dysfunction |
C0086565 |
Finding |
0.3 |
0.51 |
0.828 |
phenotype |
GPT |
2875 |
Hepatitis, Toxic |
C0019193 |
Injury or Poisoning |
0.3 |
0.51 |
0.828 |
disease |
Association with Drug
Protein Official Symbol |
Human Entrez ID |
drug_claim_primary_name |
drug_name |
drug_chembl_id |
interaction_types |
GPT |
2875 |
GLUCAGON |
GLUCAGON |
CHEMBL266481 |
None |
GPT |
2875 |
PROTEASE INHIBITOR |
None |
None |
None |
GPT |
2875 |
TACROLIMUS |
TACROLIMUS |
CHEMBL269732 |
None |